Hillsdale Investment Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,465
| Closed | -$565K | – | 653 |
|
|
2024
Q4 | $565K | Sell |
2,465
-700
| -22% | -$161K | 0.03% | 345 |
|
|
2024
Q3 | $707K | Buy |
+3,165
| New | +$696K | 0.05% | 312 |
|
|
2022
Q4 | – | Sell |
-52
| Closed | -$9K | – | 590 |
|
|
2022
Q3 | $9K | Hold |
52
| – | – | ﹤0.01% | 518 |
|
|
2022
Q2 | $11K | Hold |
52
| – | – | ﹤0.01% | 495 |
|
|
2022
Q1 | $12K | Hold |
52
| – | – | ﹤0.01% | 521 |
|
|
2021
Q4 | $14K | Sell |
52
-2,387
| -98% | -$591K | ﹤0.01% | 535 |
|
|
2021
Q3 | $590K | Sell |
2,439
-291
| -11% | -$73.3K | 0.05% | 364 |
|
|
2021
Q2 | $647K | Hold |
2,730
| – | – | 0.05% | 321 |
|
|
2021
Q1 | $598K | Sell |
2,730
-58
| -2% | -$11.6K | 0.05% | 316 |
|
|
2020
Q4 | $488K | Sell |
2,788
-116
| -4% | -$20K | 0.05% | 356 |
|
|
2020
Q3 | $470K | Buy |
+2,904
| New | +$460K | 0.05% | 330 |
|
|
2020
Q1 | – | Sell |
-3,026
| Closed | -$440K | – | 636 |
|
|
2019
Q4 | $440K | Sell |
3,026
-291
| -9% | -$42K | 0.04% | 385 |
|
|
2019
Q3 | $479K | Buy |
+3,317
| New | +$484K | 0.04% | 361 |
|
|
2018
Q3 | – | Sell |
-47
| Closed | -$7K | – | 515 |
|
|
2018
Q2 | $7K | Sell |
47
-11
| -19% | -$1.66K | ﹤0.01% | 388 |
|
|
2018
Q1 | $8K | Hold |
58
| – | – | ﹤0.01% | 358 |
|
|
2017
Q4 | $8K | Sell |
58
-2,910
| -98% | -$385K | ﹤0.01% | 367 |
|
|
2017
Q3 | $385K | Buy |
2,968
+2,910
| +5,017% | +$388K | 0.06% | 225 |
|
|
2017
Q2 | $8K | Sell |
58
-35
| -38% | -$4.29K | ﹤0.01% | 349 |
|
|
2017
Q1 | $11K | Hold |
93
| – | – | ﹤0.01% | 335 |
|
|
2016
Q4 | $10K | Hold |
93
| – | – | ﹤0.01% | 348 |
|
|
2016
Q3 | $11K | Hold |
93
| – | – | ﹤0.01% | 367 |
|
|
2016
Q2 | $10K | Sell |
93
-3,027
| -97% | -$326K | ﹤0.01% | 383 |
|
|
2016
Q1 | $314K | Sell |
3,120
-11
| -0.4% | -$1.05K | 0.11% | 266 |
|
|
2015
Q4 | $333K | Sell |
3,131
-1,746
| -36% | -$180K | 0.13% | 231 |
|
|
2015
Q3 | $454K | Buy |
4,877
+698
| +17% | +$72.2K | 0.15% | 111 |
|
|
2015
Q2 | $435K | Buy |
4,179
+3,364
| +413% | +$350K | 0.13% | 142 |
|
|
2015
Q1 | $88K | Buy |
815
+117
| +17% | +$12K | 0.02% | 419 |
|
|
2014
Q4 | $65K | Sell |
698
-699
| -50% | -$61.7K | 0.02% | 434 |
|
|
2014
Q3 | $122K | Buy |
1,397
+582
| +71% | +$52.6K | 0.04% | 370 |
|
|
2014
Q2 | $72K | Sell |
815
-116
| -12% | -$10K | 0.02% | 422 |
|
|
2014
Q1 | $79K | Sell |
931
-2,212
| -70% | -$176K | 0.02% | 402 |
|
|
2013
Q4 | $247K | Buy |
3,143
+233
| +8% | +$19.9K | 0.07% | 267 |
|
|
2013
Q3 | $248K | Buy |
+2,910
| New | +$245K | 0.07% | 255 |
|
Other funds holding LH
Hillsdale Investment Management's LH Position: Q1 2025 in Review
Hillsdale Investment Management sold out of Labcorp (LH) in Q1 2025, closing a stake of 2,465 shares — an estimated $565K sold.
Hillsdale Investment Management first reported a position in LH in Q3 2013 and held it in 33 quarters. The position peaked at $707K in Q3 2024. 973 funds tracked by Wall St. Rank hold LH as of Q1 2025.
- Hillsdale Investment Management reported no remaining Labcorp position as of Q1 2025 after selling out during the quarter.
- Hillsdale Investment Management sold 2,465 Labcorp shares in Q1 2025, an estimated $565K.
- Hillsdale Investment Management first reported a position in Labcorp in Q3 2013 and held it in 33 quarters.
- Hillsdale Investment Management's Labcorp position peaked at $707K in Q3 2024.
- 973 funds tracked by Wall St. Rank held Labcorp as of Q1 2025.
Based on Hillsdale Investment Management's 13F filing for Q1 2025, filed 9 May 2025.